BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 04/05/1999

FDA Announces Public Meeting to Discuss Approach to Assessing Preclinical Reproductive Toxicity Data

The FDA is hosting a public meeting to discuss its approach to evaluating preclinical data on reproductive toxicity in pharmaceuticals, with the goal of informing guidance on pharmaceutical reproductive risk.

Source: Federal Register — Food and Drug AdministrationOpen original release →